Translation News and Research

RSS

Stony Brook professor receives 2010 NIH Director's New Innovator Award

Balaji Sitharaman, Ph.D., Assistant Professor of Biomedical Engineering at Stony Brook University, is a 2010 recipient of the National Institutes of Health (NIH) Director's New Innovator Award.

14 Oct 2010

New York Stem Cell Foundation names first six NYSCF Investigators

In an expansion of its ongoing effort to promote the next generation of stem cell scientists, The New York Stem Cell Foundation (NYSCF) today named the first six NYSCF Investigators. Each of the NYSCF-Robertson and NYSCF-Helmsley Investigators will receive up to $1.5 million over the next five years to expand their own laboratories, train other scientists and foster innovative high-risk/high reward research to explore the therapeutic potential of stem cells derived from humans and model organisms.

13 Oct 2010

NCI rates Abramson Cancer Center as 'exceptional'

The University of Pennsylvania's Abramson Cancer Center has been rated as "exceptional" by the National Cancer Institute (NCI) during a competitive research funding review by the government agency.

13 Oct 2010

Elsevier, AMP, ASIP to publish The Journal of Molecular Diagnostics

Elsevier, a world-leading publisher of scientific, technical and medical information products and services, is pleased to announce that as of January 2011 Elsevier will publish The Journal of Molecular Diagnostics (JMD) in partnership with the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP).

12 Oct 2010

Varian and Stanford scientists receive $3.6M NIH grant to develop advanced imaging technology

Scientists from Stanford University and from the Ginzton Technology Center at Varian Medical Systems have jointly received a $3.6 million five-year research grant from the U.S. National Institutes of Health (NIH) to develop advanced imaging technology for improving the quality of CT images for patients with metal objects in their bodies such as hip implants and dental fillings.

11 Oct 2010

Cincinnati Children's Hospital Medical Center named Centers of Excellence for Molecular Hematology

Cincinnati Children's Hospital Medical Center has been named one of five national Centers of Excellence for Molecular Hematology to find new gene and cell therapies for inherited diseases affecting blood cells.

8 Oct 2010

Integra to present multi-center study of peripheral nerve repair at Mexico joint meeting

Integra LifeSciences Holdings Corporation announced today that the results of the multi-center human clinical trial comparing NeuraGen Nerve Guide with direct suture repair have been accepted, in abstract form, for presentation at the joint meeting of the American Association for Hand Surgery (AAHS), American Society for Reconstructive Microsurgery (ASRM), and American Society for Peripheral Nerve (ASPN), January 12-18, 2011, Cancun Mexico.

7 Oct 2010

Lumosity.com launches Italian version of cognitive training service

Lumosity.com, the leading online provider of games that improve brain performance, announced today the launch of an Italian version of their cognitive training service -- i.lumosity.com/it. The translation of the site into Italian was sponsored by Abbott Laboratories. Abbott also sponsored hundreds of memberships to make the Lumosity.com cognitive training program available to doctors and patients throughout Italy in an effort to raise awareness about the cognitive deficits associated with HIV/AIDS.

6 Oct 2010

NIH awards Scripps Research grants to study the mechanisms of protein complex

For Immediate Release -Scripps Research Institute scientists have been awarded approximately $65 million in four five-year grants as part of the National Institutes of Health's (NIH) latest round of structural biology funding. The projects will focus on determining the shapes and functions of proteins and protein complexes that are important in biology and medicine.

4 Oct 2010

HHS announces $473 million grant to help people make effective healthcare decisions

HHS' Agency for Healthcare Research and Quality today announced the award of $473 million in grants and contracts to support projects that will help people make health care decisions based on the best evidence of effectiveness. The funding announced today covers all of AHRQ's allocation and $173 million administered for the HHS Secretary by AHRQ.

1 Oct 2010

Tengion presents Neo-Kidney Augment development program at ISCT Symposium

Tengion, Inc. presented new research data yesterday in a podium presentation at the 2nd Annual Symposium on Stem Cell Translation of the International Society for Cellular Therapy (ISCT) in San Francisco. The presentation highlighted new results from Tengion's Neo-Kidney Augment development program demonstrating success with an autologous cellular therapy approach to kidney regeneration in a rodent model of obesity, diabetes and hypertension.

30 Sep 2010

Kaiser Permanente donates Convergent Medical Terminology to IHTSDO

Kaiser Permanente today donated its Convergent Medical Terminology (CMT) to the International Healthcare Terminology Standards Development Organisation (IHTSDO) for U.S. distribution through the U.S. Department of Health and Human Services (HHS) so that all health care providers arge and small can benefit from the translation-enabling technology.

30 Sep 2010

NIH awards $3.1 million to further fund Inovio's universal SynCon flu vaccine development

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that Inovio Pharmaceuticals and the University of Pennsylvania have received a grant of $3.1 million from the National Institutes of Health (NIH) Director's Office to further fund Inovio's universal SynCon™ flu vaccine development.

30 Sep 2010

Alnylam Pharmaceuticals publishes ALN-RSV01 Phase IIa study results

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company announced today that it has published results in the American Journal of Respiratory and Critical Care Medicine from its double-blind, placebo-controlled, randomized Phase IIa study of ALN-RSV01 in lung transplant patients naturally infected with respiratory syncytial virus (RSV).

30 Sep 2010

NHC shows disappointment over PCORI Board member appoitnments

As organizations that are committed to promoting accurate and appropriate evidence-based policies and practices to improve the quality of health care services in the United States, we are disappointed that the appointment today of 19 members to the Board of Governors for the new Patient-Centered Outcomes Research Institute (PCORI) includes only one Board member that directly represents patients.

24 Sep 2010

Belfer Institute, sanofi-aventis collaborate to discover anticancer drugs

Dana-Farber Cancer Institute's Belfer Institute of Applied Cancer Science (Belfer Institute) and sanofi-aventis announced today that they have entered into a collaboration and license option agreement to identify and validate novel oncology targets for further discovery and development by sanofi-aventis of novel therapeutics agents directed to such targets and related biomarkers.

24 Sep 2010

New professional handbook highlights fast-growing trends in scientific knowledge

As genomic advances reveal new insights into what underlies human health and disease, important questions emerge about the meaning of this information for entire families especially children and their parents. Now, a new professional handbook is available to help researchers, practitioners, and policy makers understand the impacts of these discoveries on child and family well-being.

21 Sep 2010

Immunotherapy accepted for coverage in MEDLINE®

Future Medicine Ltd announced today that its journal Immunotherapy (ISSN 1750-743X) has been selected for coverage in MEDLINE®. Maintained by the U.S. National Library of Medicine, MEDLINE® (Medical Literature Analysis and Retrieval System Online) is a premier bibliographic database containing approximately 13 million references to journal articles in life sciences.

19 Sep 2010

Researchers identify interferons may inhibit IL-1b protein production

Among the first is the production of cell factors such as interferons and IL-1beta. Interferons have several functions, including activating a series of intracellular signals such as Tyk2 (Tyrosine kinase 2), while IL-1beta is important for the induction of inflammation, which helps directly to protect the body against attack.

16 Sep 2010

Study finds GRK2 molecule promotes cell death after heart attack

A molecule known to be involved in progressive heart failure has now been shown to also lead to permanent damage after a heart attack, according to researchers at Thomas Jefferson University.

16 Sep 2010